Dmitry Zamoryakhin
Technik-/Wissenschafts-/F&E-Leiter bei BIODEXA PHARMACEUTICALS PLC
Ursprung des Netzwerks ersten Grades von Dmitry Zamoryakhin
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 12 | |
Public Company | Biotechnology | 7 | |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dmitry Zamoryakhin
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Oxford | College/University | Doctorate Degree Graduate Degree | |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Grunenthal Italia Srl
Grunenthal Italia Srl Pharmaceuticals: MajorHealth Technology Grunenthal Italia Srl is an Italian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Milan, Italy. The CEO of the company is Gabriel Baertschi. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
ERGOMED | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Midatech Pharma (Wales) Ltd.
Midatech Pharma (Wales) Ltd. Pharmaceuticals: MajorHealth Technology Midatech Pharma (Wales) Ltd. develops advanced life science and therapeutic products. The company was founded on October 10, 2003 and is headquartered in Cardiff, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
RENEURON GROUP PLC | Pharmaceuticals: Major | Chief Executive Officer | |
RWTH Aachen University | College/University | Corporate Officer/Principal | |
Syneos Health NC LLC
Syneos Health NC LLC Miscellaneous Commercial ServicesCommercial Services Syneos Health LLC operates therapeutically focused global contract research organization. It provides pharma and biotech services. The firm specializes in the hematology, immunology and inflammation infectious diseases, oncology, ophthalmology, cardiovascular, CNS analgesia, CNS neurology, CNS psychiatry, endocrinology, and gastroenterology and hepatology. The company was founded by Kenneth A. Selzer in 1985 and is headquartered in Raleigh, NC. | Miscellaneous Commercial Services | Director/Board Member | |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Biotechnology | Chairman | |
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Pharmaceuticals: Major | Director of Finance/CFO | |
Peel Hunt LLP
Peel Hunt LLP Investment Banks/BrokersFinance Peel Hunt LLP is an independent securities brokerage firm headquartered in London, UK. The firm was founded in 1989 as a market liquidity provider to retail and institutional investors. They provide bespoke dealing and execution services for institutional asset managers, registrars, private client wealth managers and private banks. | Investment Banks/Brokers | Sales & Marketing | |
BENEVOLENTAI | Biotechnology | Director of Finance/CFO | |
Proteros biostructures GmbH
Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Medical/Nursing Services | Chairman | |
University of Dortmund | College/University | Doctorate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Grünenthal Pharma GmbH & Co. KG
Grünenthal Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Grünenthal Pharma GmbH & Co. KG engages in the development and manufacture of pharmaceutical products. It specializes in the treatment of pain and inflammation. The company is headquartered in Aachen, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
MedXCell SA
MedXCell SA BiotechnologyHealth Technology MedXCell SA is a European cell therapy venture builder that focuses on identifying scientific breakthroughs and transforming them into clinical assets. The private company is based in Montreux, Switzerland. The Swiss company has a strong industrial mindset and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development, and funding capabilities. MedXCell scouts for promising ideas within its European academic network of partners, selects the most commercially-viable ideas, and co-develops them with academic institutions until the proof-of-principle stage. The company creates pipeline companies based on those ideas that can be funded independently and monetizes those that can be sold or out-licensed as early-stage assets. MedXCell was founded in 2016 by Laurent Zbinden, who has been the CEO since then. | Biotechnology | Director/Board Member | |
LABORATORIOS ANDROMACO S.A. | Pharmaceuticals: Major | Director/Board Member | |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Gensmile Ltd.
Gensmile Ltd. Medical/Nursing ServicesHealth Services Gensmile Ltd. is a dental group that aims to provide quality dentistry and a better experience for both patients and clinicians. The private company is based in Easton Royal, UK, and has subsidiaries in the United Kingdom. Gensmile understands that selling a dental practice can be a significant financial and emotional decision for many dentists. The British company was founded in 2014 and has since acquired 16 practices and 2 Dental Labs. | Medical/Nursing Services | Founder | |
University of London | College/University | Doctorate Degree | |
Archimedes Pharma Ltd.
Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Harefield Pharmacovigilance Ltd.
Harefield Pharmacovigilance Ltd. BiotechnologyHealth Technology Harefield Pharmacovigilance Ltd. engages in the provision of drug safety services. The company was founded on August 23, 2007 and is headquartered in Guildford, the United Kingdom. | Biotechnology | Director/Board Member | |
Index Ventures SA
Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Corporate Officer/Principal | |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK. | Pharmaceuticals: Major | Director/Board Member | |
Behringwerke AG
Behringwerke AG Pharmaceuticals: OtherHealth Technology Part of Sanofi, Behringwerke AG is a German company that produces specialty chemicals and pharmaceutical products. The company is based in Marburg, Germany. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
OpsiRx Pharmaceuticals Ltd.
OpsiRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology OpsiRx Pharmaceuticals Ltd. is a British company that manufactures pharmaceutical products. The private company is based in Cardiff, UK. | Pharmaceuticals: Major | Chairman | |
Warburg Pincus LLP | Corporate Officer/Principal | ||
Lazard & Co. Holdings Ltd.
Lazard & Co. Holdings Ltd. Financial ConglomeratesFinance Part of Lazard Ltd., Lazard & Co. Holdings Ltd. is a financial advisory and British investment solutions company. The company is based in London, UK. The company's mission is to provide trusted and independent financial advice to its clients, backed by the intellectual capital of the firm. Lazard has been a leading advisor to debtors and creditors in the world's largest and most complex restructurings for decades. | Financial Conglomerates | Corporate Officer/Principal | |
Gensmile Dental Care Ltd.
Gensmile Dental Care Ltd. Medical/Nursing ServicesHealth Services Part of Gensmile Ltd., Gensmile Dental Care Ltd. provides dental care services. The company is based in Pewsey, UK. Founded in 2015. | Medical/Nursing Services | Director/Board Member | |
DKSH HOLDING AG | Medical Distributors | Director/Board Member | |
Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree | |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Tornier, Inc.
Tornier, Inc. Hospital/Nursing ManagementHealth Services Tornier, Inc. provides healthcare services and distributes medical devices. It offers joint replacement products including hips, knees, shoulders, ankles, and other extremity prostheses. The company is headquartered in Bloomington, MN. | Hospital/Nursing Management | Director/Board Member | |
Genextra SpA
Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Investment Managers | Corporate Officer/Principal | |
AstraZeneca KK
AstraZeneca KK Pharmaceuticals: MajorHealth Technology AstraZeneca KK develops, manufactures and sells prescription drugs. It also conducts medical research. The company was founded on April 11, 1975 and is headquartered in Osaka, Japan. | Pharmaceuticals: Major | President | |
The University of Exeter | College/University | Doctorate Degree | |
EXSCIENTIA PLC | Biotechnology | Director/Board Member | |
Moelis & Co. (UK) LLP
Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Part of Moelis & Co., Moelis & Co. (UK) LLP is an independent investment bank that provides confidential and unconflicted strategic advice to clients across various industries. The company is based in London, UK. Leveraging their extensive network of 21 geographic locations, the British company delivers the best solutions to their clients. Mark Jonathan Aedy has been the CEO of the company since 2010. | Investment Banks/Brokers | Corporate Officer/Principal |
Statistik
International
Vereinigtes Königreich | 23 |
Deutschland | 9 |
Vereinigte Staaten | 8 |
Schweiz | 5 |
Italien | 3 |
Sektoral
Health Technology | 26 |
Consumer Services | 8 |
Finance | 7 |
Commercial Services | 5 |
Health Services | 5 |
Operativ
Director/Board Member | 80 |
Corporate Officer/Principal | 39 |
Chairman | 30 |
Chief Executive Officer | 18 |
Director of Finance/CFO | 13 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Stephen Parker | 34 |
Frederic Roch Doliveux | 21 |
Simon Turton | 16 |
Stephen Stamp | 15 |
Rolf Stahel | 13 |
Robert Ghenchev | 13 |
Lorenzo M. Tallarigo | 11 |
Sijmen de Vries | 10 |
Eric-Paul Pâques | 10 |
Gabriel Baertschi | 9 |
Ann Merchant | 8 |
Natalie Walter | 7 |
Siyamak Rasty | 6 |
Steve Damment | 5 |
Catherine Isted | 5 |
- Börse
- Insiders
- Dmitry Zamoryakhin
- Unternehmensverbindungen